Trial Profile
Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic Cancer: A Pilot Single Arm Phase II Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Feb 2021
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Paclitaxel (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 29 Jan 2021 Status changed from recruiting to completed.
- 02 Feb 2018 New trial record